All Access Articles |
- Analyzing Market Sentiment Impact on BBIO's Price Surge | 2025-11-21 | PHARMACEUTICAL
- Navigating BridgeBio Pharma (BBIO) Stock – Key Insights for Investors | 2025-11-10 | PHARMACEUTICAL
- Brief Overview for BridgeBio Pharma Shareholders | 2025-10-28 | PHARMACEUTICAL
- Unveiling BridgeBio Pharma – A Fundamental Analysis | 2025-08-18 | PHARMACEUTICAL
- Brief Report on BridgeBio Pharma Stock | 2025-08-12 | PHARMACEUTICAL
- Analyzing the Future of BridgeBio Pharma Stock | 2025-07-14 | PHARMACEUTICAL
- Navigating BBIO – Key Insights for Investors | 2025-06-30 | PHARMACEUTICAL
- BridgeBio Pharma 10-Q Report Reveals Diverse Pipeline and FDA Approvals | 2025-04-30 | PHARMACEUTICAL
- Analyzing the Reasons Behind BBIO's Stock Decline | 2025-02-25 | PHARMACEUTICAL
- BridgeBio Pharma Reports Positive Results in Phase 2 Trial of Infigratinib for Achondroplasia | 2024-06-06 | PHARMACEUTICAL
- Quick Briefing on BridgeBio Pharma | 2023-12-02 | UNITED STATES